1. Home
  2. Analysis
  3. Droperidol
  4. Nasonex

Droperidol and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Droperidol (droperidol) and Nasonex (mometasone furoate monohydrate). Common drug interactions include hypoacusis among females and anaphylactic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Droperidol and Nasonex. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,452 Droperidol users. Check the latest studies of Droperidol.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

On Jul, 24, 2026

11 people who take Droperidol and Nasonex together, and have interactions are studied.

Droperidol and Nasonex drug interactions.

What are the common drug interactions of Droperidol and Nasonex, by gender? *:

female:

  1. Hypoacusis (loss of hearing)
  2. Chest pain
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Dyspnoea (difficult or laboured respiration)
  5. Headache (pain in head)
  6. Pain
  7. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

What are the common drug interactions of Droperidol and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest pain
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Dyspnoea (difficult or laboured respiration)
  4. Headache (pain in head)
  5. Pain
  6. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

  1. Hypoacusis (loss of hearing)

60+:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

What are the existing conditions these people have? *

  1. Anaesthesia: 7 people, 63.64%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 9.09%
  3. Premenstrual Syndrome: 1 person, 9.09%
  4. Pain: 1 person, 9.09%
  5. Multiple Allergies (allergy to multiple agents): 1 person, 9.09%
  6. Migraine (headache): 1 person, 9.09%
  7. Acne (skin problems that cause pimples): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Droperidol and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Droperidol and Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Droperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on droperidol and mometasone furoate monohydrate (the active ingredients of Droperidol and Nasonex, respectively), and Droperidol and Nasonex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.